EX-10.1
from 10-Q
62 pages
Confidential Material Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Such Omissions. Development, License and Marketing Agreement by and Among Jagotec AG, Skyepharma PLC (In Connection With Parent Guaranty Only), Kos Life Sciences, Inc. and Kos Pharmaceuticals, Inc. (In Connection With Parent Guaranty Only) Dated as of May 5, 2006
12/34/56